Gregory J. Tiesi, MD, FACS, FSSO

Gregory J. Tiesi, MD, FACS, FSSO, is the medical director of Hepatobiliary Surgery at the Hackensack Meridian Jersey Shore University Medical Center

Articles by Gregory J. Tiesi, MD, FACS, FSSO

Trans-Arterial Microperfusion in Pancreatic Adenocarcinoma: ©Image by Ashling Wahner & MJH Life Sciences Using AI

Transarterial Microperfusion for Pancreatic Adenocarcinoma: A New Way of Addressing an Old Problem

ByGregory J. Tiesi, MD, FACS, FSSO

December 22nd 2025

Pancreatic ductal adenocarcinoma remains highly lethal due to late presentation, treatment resistance, and limited drug delivery with standard systemic therapies.

Gregory J. Tiesi, MD, FACS, FSSO, medical director, Hepatobiliary Surgery, Hackensack Meridian Jersey Shore University Medical Center; Anthony Scholer, MD, FACS, FSSO, surgical oncologist, hepatobiliary surgery, Hackensack Meridian Medical Group and Jersey Shore University Medical Center; Benjamin Jon Golas, MD, FACS, regional chief, Surgical Oncology, Hackensack Meridian Health’s Central Region, surgical director, Oncology Services, Jersey Shore University Medical Center, vice chair, Surgery, Jersey Shore University Medical Center Cancer Surgery, associate professor, surgery, Hackensack Meridian School of Medicine; Eric Pletcher, MD, surgeon, Complex General Surgical Oncology, Hackensack Meridian JFK University Medical Center

Hepatic Artery Infusion Refines Liver-Directed Care for GI Cancers: With Gregory J. Tiesi, MD, FACS, FSSO; Anthony Scholer, MD, FACS, FSSO; Benjamin Jon Golas, MD, FACS; and Eric Pletcher, MD

ByGregory J. Tiesi, MD, FACS, FSSO,Anthony Scholer, MD, FACS, FSSO,Benjamin Jon Golas, MD, FACS,Eric Pletcher, MD

December 9th 2025

Drs Tiesi, Scholer, Golas, and Pletcher discuss the use of hepatic artery infusion in colon cancer and liver cancer management.

PIPAC Reshapes Peritoneal Cancer Surgery Workflows and Outcomes: With Gregory J. Tiesi, MD, FACS, FSSO; Anthony Scholer, MD, FACS, FSSO; Benjamin Jon Golas, MD, FACS; and Eric Pletcher, MD

ByGregory J. Tiesi, MD, FACS, FSSO,Anthony Scholer, MD, FACS, FSSO,Benjamin Jon Golas, MD, FACS,Eric Pletcher, MD

December 3rd 2025

Drs Tiesi, Scholer, Golas, and Pletcher discussed the use of PIPAC, a minimally invasive regional cancer therapy, in patients with peritoneal cancers.

Latest Updated Articles

PIPAC Reshapes Peritoneal Cancer Surgery Workflows and Outcomes: With Gregory J. Tiesi, MD, FACS, FSSO; Anthony Scholer, MD, FACS, FSSO; Benjamin Jon Golas, MD, FACS; and Eric Pletcher, MD
Published: December 3rd 2025 | Updated:
Hepatic Artery Infusion Refines Liver-Directed Care for GI Cancers: With Gregory J. Tiesi, MD, FACS, FSSO; Anthony Scholer, MD, FACS, FSSO; Benjamin Jon Golas, MD, FACS; and Eric Pletcher, MD
Published: December 9th 2025 | Updated:
Transarterial Microperfusion for Pancreatic Adenocarcinoma: A New Way of Addressing an Old Problem
Published: December 22nd 2025 | Updated:

Gregory J. Tiesi, MD, FACS, FSSO

Articles by Gregory J. Tiesi, MD, FACS, FSSO

Transarterial Microperfusion for Pancreatic Adenocarcinoma: A New Way of Addressing an Old Problem

Hepatic Artery Infusion Refines Liver-Directed Care for GI Cancers: With Gregory J. Tiesi, MD, FACS, FSSO; Anthony Scholer, MD, FACS, FSSO; Benjamin Jon Golas, MD, FACS; and Eric Pletcher, MD

PIPAC Reshapes Peritoneal Cancer Surgery Workflows and Outcomes: With Gregory J. Tiesi, MD, FACS, FSSO; Anthony Scholer, MD, FACS, FSSO; Benjamin Jon Golas, MD, FACS; and Eric Pletcher, MD

Latest Updated Articles

Trending on OncLive

Unpacking the FDA Approvals That Reshaped Cancer Care in 2025

Nogapendekin Alfa Inbakicept Plus NK Cell Therapy Yields Strong OS Signal in Recurrent Glioblastoma

FDA Grants Orphan Drug Designation to Gotistobart in Squamous NSCLC

WJ01024 Is Safe, Drives Durable Spleen Responses in R/R Myelofibrosis

A Guide to Interviewing for Hematology/Oncology Fellowship From a Chief Fellow